Global Electrosurgery Devices Market Fueled by New Minimally Invasive Surgery Techniques
|
By HospiMedica International staff writers Posted on 08 Jun 2022 |

Various types of surgeries such as cosmetic, cardiovascular, and gynecological procedures, require precision and are time-sensitive. Electrosurgery devices such as generators, active electrodes, and others make it easier and less time-consuming to perform such surgeries, thereby driving their demand. The COVID-19 pandemic had forced end-users to prioritize treatments and restricted the growth of the electrosurgery market. The market is currently in the recovery stage with new developments being witnessed in the manufacturing of these devices such as electrosurgery generators, instruments, and bipolar instruments. The global electrosurgery devices market is projected to grow at a CAGR of 4.4% from an estimated USD 3.3 billion in 2022 to over USD 5 billion by 2032, driven by technologically-advanced tools and their use in major applications in medical, cosmetics, and age-related surgeries being performed.
These are the latest findings of Future Market Insights (Newark, DE, USA), a market research organization.
The rise in chronic and lifestyle diseases is creating the need for specific treatments that includes multiple surgeries and is driving the electrosurgery devices market. New minimally invasive surgery techniques and related technologies are fueling the sales of electrosurgery devices, including generators and other instruments. Governments around the world are adopting new cutting-edge technologies to enhance their healthcare system, including for the treatment of chronic diseases that involve surgeries. The major adoption of electrosurgery devices is in hospitals, clinics, and ablation centers and the rising number of ambulatory surgery centers is contributing further to the market growth.
Based on product, the electrosurgery instruments & accessories segment holds the largest share of the electrosurgery devices market and is expected to register a CAGR of 4.2% through the forecast period, driven by factors such as high usage in the medical and cosmetic sector, and affordable prices due to common usage. Based on application, the general surgery segment holds the largest share of the electrosurgery devices market and is expected to register a CAGR of 4.1% through the forecast period, led by common usage and new technological developments in the field of general surgery.
Geographically, the US electrosurgery devices market is expected to record the fastest CAGR of 3.9% during the forecast period and surpass USD 1.7 billion by 2032, on the back of new trends in the cosmetic industry, high obesity rates and high capital investment in healthcare. China’s electrosurgery devices market is projected to record the second-fastest CAGR of 3.7% during the forecast period to reach USD 347 million by the end of 2032, alongside Japan and South Korea.
Related Links:
Future Market Insights
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







